‘Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study’ by Miao Cai et al. was published in The BMJ at 23:30 hours UK time ...
“Overall, the study reinforces that GLP-1 receptor agonists are unlikely to produce durable weight loss if used as short term interventions without longer term management plans. For many patients, ...
“The study uses an unusual approach in combining the results from smokers (who had higher blood pressure and cholesterol than the controls) and vapers (who did not) to claim that both are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results